Stock Report

Suven Life Sciences reports consolidated loss of Rs. 33.69 crores in Q3FY22

Posted On : 2022-01-31 13:09:39( TIMEZONE : IST )

Suven Life Sciences Limited has reported Consolidated financial results for the period ended December 31, 2021.

Financial Results (Q3 FY2022) - QoQ Comparison

The company has reported total income of Rs. 4.5738 crores during the period ended December 31, 2021 as compared to Rs. 1.6869 crores during the period ended September 30, 2021.

The company has posted net profit / (loss) of Rs. -33.6903 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs. -28.2982 crores for the period ended September 30, 2021.

The company has reported EPS of Rs. -2.65 for the period ended December 31, 2021 as compared to Rs. -2.22 for the period ended September 30, 2021.

Financials	Q3 FY2022	Q2 FY2022	% Change
Total Income	₹4.5738 crs	₹1.6869 crs	171.14%
Net Profit	₹-33.6903 crs	₹-28.2982 crs	19.05%
EPS	₹-2.65	₹-2.22	19.37%

Financial Results (Q3 FY2022) - YoY Comparison

The company has reported total income of Rs.4.5738 crores during the period ended December 31, 2021 as compared to Rs.3.1371 crores during the period ended December 31, 2020.

The company has posted net profit / (loss) of Rs.-33.6903 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs.-24.3929 crores for the period ended December 31, 2020.

The company has reported EPS of Rs.-2.65 for the period ended December 31, 2021 as compared to Rs.-1.92 for the period ended December 31, 2020.

Financials	Q3 FY2022	Q3 FY2021	% Change
Total Income	₹4.5738 crs	₹3.1371 crs	45.80%
Net Profit	₹-33.6903 crs	₹-24.3929 crs	38.12%
EPS	₹-2.65	₹-1.92	38.02%

Financial Results (9 Months Ended FY2022) - YoY Comparison

The company has reported total income of Rs.12.8220 crores during the 9 Months period ended December 31, 2021 as compared to Rs.18.3518 crores during the 9 Months period ended December 31, 2020.

The company has posted net profit / (loss) of Rs.-101.1970 crores for the 9 Months period ended December 31, 2021 as against net profit / (loss) of Rs.-50.5388 crores for the 9 Months period ended December 31, 2020.

The company has reported EPS of Rs.-7.95 for the 9 Months period ended December 31, 2021 as compared to Rs.-3.97 for the 9 Months period ended December 31, 2020.

Financials	9 Months Ended FY2022	9 Months Ended FY2021	% Change
Total Income	₹12.8220 crs	₹18.3518 crs	-30.13%
Net Profit	₹-101.1970 crs	₹-50.5388 crs	100.24%
EPS	₹-7.95	₹-3.97	100.25%

Shares of Suven Life Sciences Limited was last trading in BSE at Rs. 89.30 as compared to the previous close of Rs. 88.55. The total number of shares traded during the day was 34871 in over 991 trades.

The stock hit an intraday high of Rs. 91.55 and intraday low of 88.45. The net turnover during the day was Rs. 3143518.00.